RILEY JENNIFER (Chief Strategy Officer) sold 6.7% of their position (2.65K shares) of AVALO THERAPEUTICS, INC. on the open market
Open‑market sale worth $52.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/12/2026ACC: 0002047607-26-000008
Officer· Chief Strategy Officer
Since Feb 2026
-2.65K
Net shares
Net seller
$52.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.65K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.65K
Price / share
$19.59
Trade value
$52.01K
% of position
6.7%
8/11/2026
39.70K→37.04K
Total
Net shares
−2.65K
Net value
-$52.01K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/11/2026 | S · Sale | −2.65K | $19.59 | $52.01K | 6.7% | 39.70K | 37.04K |
| Total | −2.65K | -$52.01K | ||||||
Derivative Transactions0
No derivative transactions reported